ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADMA ADMA Biologics

Pre-Mkt 05-21 07:00:56 EDT

8.56

-0.07

-0.81%

盘前8.50

-0.06-0.70%

07:00 EDT

High8.78	Low8.49	Vol4.54M
Open8.60	D1 Closing8.63	Amplitude3.36%
Mkt Cap1.99B	Tradable Cap1.94B	Total Shares232.32M
T/O39.10M	T/O Rate2.00%	Tradable Shares227.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADMA","market":"US","secType":"STK","nameCN":"ADMA Biologics","latestPrice":8.56,"timestamp":1779307200000,"preClose":8.63,"halted":0,"volume":4541971,"hourTrading":{"tag":"盘前","latestPrice":8.5,"preClose":8.56,"latestTime":"07:00 EDT","volume":721,"amount":6230.093225999999,"timestamp":1779361222654,"change":-0.06,"changeRate":-0.007009,"amplitude":0.045561},"delay":0,"changeRate":-0.008111239860950206,"floatShares":227000000,"shares":232324283,"eps":0.68,"marketStatus":"Pre-Mkt","change":-0.07,"latestTime":"05-21 07:00:56 EDT","open":8.6,"high":8.78,"low":8.49,"amount":39104562.605542004,"amplitude":0.033604,"askPrice":8.66,"askSize":93,"bidPrice":7.79,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.68,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779370200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.56,"preHourTrading":{"tag":"盘前","latestPrice":8.5,"preClose":8.56,"latestTime":"07:00 EDT","volume":721,"amount":6230.093225999999,"timestamp":1779361222654,"change":-0.06,"changeRate":-0.007009,"amplitude":0.045561},"postHourTrading":{"tag":"盘后","latestPrice":8.58,"preClose":8.56,"latestTime":"19:40 EDT","volume":85354,"amount":730643.6222,"timestamp":1779320435057,"change":0.02,"changeRate":0.002336,"amplitude":0.002336},"volumeRatio":1.2807042486289921,"impliedVol":0.6738,"impliedVolPercentile":0.68},"requestUrl":"/m/hq/s/ADMA","defaultTab":"news","newsList":[{"id":"2635618719","title":"ADMA Biologics director Jerrold B. Grossman acquires USD 100,125 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2635618719","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635618719?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:01","pubTimestamp":1778756477,"startTime":"0","endTime":"0","summary":"ADMA Biologics director Jerrold B. Grossman reported an open-market purchase of 12,500 common shares at USD 8.01.Directly held common shares rose to 513,884 following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL99zN5w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ADMA Biologics director Jerrold B. Grossman acquires USD 100,125 common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635735762","title":"A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations","url":"https://stock-news.laohu8.com/highlight/detail?id=2635735762","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635735762?lang=en_us&edition=fundamental","pubTime":"2026-05-13 08:58","pubTimestamp":1778633917,"startTime":"0","endTime":"0","summary":"ADMA Biologics (ADMA) stock has been in focus after short seller Culper Research alleged channel stuffing related to ASCENIV, prompting multiple securities law firms to launch investigations and potential class action lawsuits.\nSee our latest analysis for ADMA Biologics.\nAt a share price of $8.41, ADMA’s recent trading reflects sharp swings, with a 1-day share price gain of 6.73% sitting against a 7-day decline of 17.95% and a 90-day fall of 48.34%. The 5-year total shareholder return remains...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/a-look-at-adma-biologics-adma-valuation-after-short-seller-a-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adma/adma-biologics/news/a-look-at-adma-biologics-adma-valuation-after-short-seller-a-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635222320","title":"ADMA Biologics director Jerrold B Grossman acquires $100,125 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2635222320","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635222320?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:23","pubTimestamp":1778621010,"startTime":"0","endTime":"0","summary":"ADMA Biologics director Jerrold B. Grossman reported an open-market purchase of 12,500 common shares at USD 8.01 each.Directly held stake rose to 501,384 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL1jwvlg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ADMA Biologics director Jerrold B Grossman acquires $100,125 in common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198454723","title":"Stock Track | ADMA Biologics Soars 5.31% Intraday on Strong Q1 Earnings Fueled by ASCENIV","url":"https://stock-news.laohu8.com/highlight/detail?id=1198454723","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198454723?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:39","pubTimestamp":1778247567,"startTime":"0","endTime":"0","summary":"ADMA Biologics' stock price surged 5.31% during intraday trading on Friday, following the company's positive first-quarter earnings report released the previous evening.The significant price increase...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633816100","title":"ADMA Biologics Earnings Call: ASCENIV Fuels Profits","url":"https://stock-news.laohu8.com/highlight/detail?id=2633816100","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633816100?lang=en_us&edition=fundamental","pubTime":"2026-05-08 10:24","pubTimestamp":1778207094,"startTime":"0","endTime":"0","summary":"ADMA Biologics Inc (($ADMA)) has held its Q1 earnings call. Read on for the main highlights of the call. ADMA Biologics’ latest earnings call struc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adma-biologics-earnings-call-asceniv-fuels-profits?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adma-biologics-earnings-call-asceniv-fuels-profits?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144952","title":"ADMA Biologics Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144952","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144952?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:04","pubTimestamp":1778155440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 07, 2026 08:04 ET (12:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633148615","title":"ADMA Biologics Inc : Mizuho Cuts Target Price to $20 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2633148615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633148615?lang=en_us&edition=fundamental","pubTime":"2026-05-07 18:42","pubTimestamp":1778150572,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157930884","title":"Stock Track | ADMA Biologics Plunges 21.63% in Pre-market on Earnings Miss and Withdrawn Long-Term Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1157930884","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157930884?lang=en_us&edition=fundamental","pubTime":"2026-05-07 16:15","pubTimestamp":1778141757,"startTime":"0","endTime":"0","summary":"ADMA Biologics' stock experienced a pre-market plunge of 21.63% on Thursday, following the release of its first-quarter financial results.The specialty biologics maker reported Q1 revenue of $114.5...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160683313","title":"Stock Track | ADMA Biologics Plunges 24% Post-Market on Earnings Miss and Withdrawn Long-Term Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1160683313","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160683313?lang=en_us&edition=fundamental","pubTime":"2026-05-07 08:04","pubTimestamp":1778112296,"startTime":"0","endTime":"0","summary":"ADMA Biologics' stock plummeted 24.01% in post-market trading on Wednesday, following the release of disappointing first-quarter financial results and the withdrawal of the company's long-term...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120249587","title":"Stock Track | ADMA Biologics Plunges 26.88% After-Hours on Earnings Miss and Withdrawn Long-Term Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=1120249587","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120249587?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:43","pubTimestamp":1778100226,"startTime":"0","endTime":"0","summary":"ADMA Biologics shares plummeted 26.88% in after-hours trading on Wednesday, following the release of the company's first quarter 2026 financial results.The specialty biologics maker reported Q1...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633415284","title":"ADMA Biologics withdraws long-term outlook on competitive dynamics in PDT & IG market","url":"https://stock-news.laohu8.com/highlight/detail?id=2633415284","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633415284?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:22","pubTimestamp":1778098968,"startTime":"0","endTime":"0","summary":"ADMA Biologics withdraws long-term outlook on competitive dynamics in PDT &IG marketOverviewU.S. specialty biologics maker's Q1 revenue flat yr/yr, missing analyst expectationsAdjusted net income for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL1N41J1DQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633528731","title":"ADMA Biologics 1Q26 adjusted net income rises 22% to $40.7 million; revenue flat at $114.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633528731","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633528731?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:22","pubTimestamp":1778098943,"startTime":"0","endTime":"0","summary":"ADMA Biologics posted 1Q 2026 net income of USD 45.3 million, up 68% year over year, while revenue was flat at USD 114.5 million.Gross margin widened to 71% from 53% a year earlier, due to a shift toward higher-margin ASCENIV and impact from yield-enhanced manufacturing approved in 2025.ASCENIV revenue rose 28% year over year to USD 97.5 million, while BIVIGAM revenue dropped 54% to USD 15.4 million amid increased competitive dynamics and distributor ordering variability in U.S. plasma-derived therapies and immunoglobulin.Operating cash flow totaled USD 58 million; management said April demand supports a 2Q run rate in line with 1Q direct sales, with early signs of normalization in ordering patterns.ADMA forecast FY 2026 revenue of USD 530 million to USD 560 million, while withdrawing long-term guidance to reflect evolving U.S. plasma products and IG market competitive dynamics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL6t91dd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","ADMA","SG9999014013.SGD","SG9999014039.USD","BK4112","LU0314104364.USD","IE00BN0W2W23.USD","LU2210150020.SGD","BK4588","LU2095319765.USD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4139","SG9999014005.SGD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633563154","title":"ADMA Biologics Shares Fall 22% to $7.85  After the Bell Following Results, Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2633563154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633563154?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:16","pubTimestamp":1778098601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL6N41J190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633715159","title":"BRIEF-ADMA Biologics Q1 Revenue USD 114.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633715159","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633715159?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097953,"startTime":"0","endTime":"0","summary":"BRIEF-ADMA Biologics Q1 Revenue USD 114.5 Million\n\n\nMay 06 (Reuters) - ADMA Biologics Q1 adjusted net income USD 40.7 million.\n\nQ1 adjusted EBITDA USD 59.7 million\noutlook FY revenue USD 530-560 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX1F3B91:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633159756","title":"ADMA Biologics Outlook FY Revenue USD 530-560 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633159756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633159756?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097910,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX1F3B91:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ADMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633154012","title":"ADMA Biologics Inc - Expects FY 2026 Adj Ebitda of $265 Mln-$300 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2633154012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633154012?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097910,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX1F3B91:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633154010","title":"ADMA Biologics Inc - Withdraws Long-Term Guidance Due to Competitive Dynamics Dynamics in the Pdt & Ig Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2633154010","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633154010?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097910,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX1F3B91:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633152359","title":"ADMA Biologics Q1 EPS USD 0.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2633152359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633152359?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097910,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLX1F3B91:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADMA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633185480","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2633185480","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633185480?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:00","pubTimestamp":1778061600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Alpha & Omega                                   3Q      (.36)   4:01 PM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARRY","APP","BLLN","BVS","CF","ASTE","BBD","CDE","AMCR","ALVO","CGNX","ARQT","BKD","APO","BWA","ADMA","BRLT","ATO","ARQ","ALB","AOSL","ARM","BBSI","BRKR","BLBD","BYND","AXON","BCO","ACAD","BMEA","BTMD","CDLX","BKH","ACVA","AUGO","BLMN","AZTA","BROS","AGL","AUR","AEVA","AMH","AMPL","ALLO","APA","ATRA","ALNT","CDW","ADNT","BCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632937125","title":"ADMA Biologics wins FDA nod expanding ASCENIV label to immune-compromised children 2+","url":"https://stock-news.laohu8.com/highlight/detail?id=2632937125","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632937125?lang=en_us&edition=fundamental","pubTime":"2026-05-04 19:05","pubTimestamp":1777892707,"startTime":"0","endTime":"0","summary":"FDA cleared ADMA Biologics’ supplemental BLA for ASCENIV, expanding US labeling to include pediatric primary humoral immunodeficiency patients aged 2 years and older.Labeling change lowers prior age cutoff from 12 years, widening eligible patient population for the IVIG product.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL7ssq00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","NDAQ","ADMA","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","BK4588","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.admabiologics.com","stockEarnings":[{"period":"1week","weight":0.0071},{"period":"1month","weight":-0.2132},{"period":"3month","weight":-0.4755},{"period":"6month","weight":-0.5017},{"period":"1year","weight":-0.5812},{"period":"ytd","weight":-0.5307}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.0459},{"period":"3month","weight":0.0829},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.2503},{"period":"ytd","weight":0.087}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.021016},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01871},{"month":3,"riseRate":0.583333,"avgChangeRate":0.064012},{"month":4,"riseRate":0.666667,"avgChangeRate":0.034208},{"month":5,"riseRate":0.583333,"avgChangeRate":0.035731},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.056361},{"month":7,"riseRate":0.727273,"avgChangeRate":0.105206},{"month":8,"riseRate":0.272727,"avgChangeRate":0.003287},{"month":9,"riseRate":0.181818,"avgChangeRate":-0.032166},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.041559},{"month":11,"riseRate":0.636364,"avgChangeRate":0.093715},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.060542}],"exchange":"NASDAQ","name":"ADMA Biologics","nameEN":"ADMA Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ADMA Biologics(ADMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ADMA Biologics,ADMA,ADMA Biologics股票,ADMA Biologics股票老虎,ADMA Biologics股票老虎国际,ADMA Biologics行情,ADMA Biologics股票行情,ADMA Biologics股价,ADMA Biologics股市,ADMA Biologics股票价格,ADMA Biologics股票交易,ADMA Biologics股票购买,ADMA Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ADMA Biologics(ADMA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ADMA Biologics(ADMA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}